Equity Research firms currently have a positive stance on shares of Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP). The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.80. This is based on the research brokerage reports taken into consideration by Thomson Reuters. Those same analysts are projecting that the stock will reach $18.33 on a short term basis.
At the time of writing, the stock was trading at $13.92. This represents a change from the opening price of -7.88%. In terms of performance, year to date, the stock is 16.35%. The monthly stock performance comes in at 18.63%. For the quarter, shares are performing at 97.28%. Weekly performance analysis shows the equity at 0.97%.
In taking a look at technical levels, shares are trading 26.77% away from the 50 day simple moving average and 47.56% away from the 200 day simple moving average. Based on a recent bid, the stock is trading -16.90% away from it’s 52- week high and 131.46% away from its 52 week low. After the recent moves, investors may also look to see if the stock has entered oversold or overbought territory and could be ripe for a bounce. As of writing, Aquinox Pharmaceuticals Inc.’s RSI stands at 58.96. In looking at volatility levels, the shares saw weekly volatility of 6.47% and 7.80% over the past month.